Tine leukocidin and highly lethal necrotising pneumonia in young immunocompetent sufferers. Lancet 359: 753759. 3. Konig B, Koller M, Prevost G, Piemont Y, Alouf JE, et al. Activation of human effector cells by diverse bacterial toxins: generation of interleukin-8. Infection and immunity 62: 48314837. 4. Perret M, Badiou C, Lina G, Burbaud S, Benito Y, et al. Cross-talk amongst Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. Cellular microbiology 14: 10191036. five. Holzinger D, Gieldon L, Mysore V, Nippe N, Taxman DJ, et al. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes through the NLRP3 inflammasome. Journal of leukocyte biology 17460038 92: 10691081. 6. Williams MR, Azcutia V, Newton G, Alcaide P, Luscinskas FW Emerging mechanisms of neutrophil recruitment across endothelium. Trends in immunology 32: 461469. 7. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proceedings with the National Academy of Sciences from the Usa of America 107: 55875592. 8. Dinarello CA, Simon A, van der Meer JW Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nature critiques Drug discovery 11: 633652. 9. Giampietro C, Ridene M, Lequerre T, Costedoat Chalumeau N, Amoura Z, et al. Anakinra in adult-onset Still’s illness: long-term remedy in patients resistant to conventional therapy. Arthritis care & research 65: 822826. 10. Voyich JM, Otto M, PHCCC cost Mathema B, Braughton KR, Whitney AR, et al. Is Panton-Valentine leukocidin the major virulence determinant in communityassociated methicillin-resistant Staphylococcus aureus disease The Journal of infectious ailments 194: 17611770. 11. Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, et al. The staphylococcal toxin panton-valentine leukocidin targets human c5a receptors. Cell host & microbe 13: 584594. 12. Croisier-Bertin D, Piroth L, Charles PE, Larribeau A, Biek D, et al. Ceftaroline versus ceftriaxone within a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing. Antimicrobial agents and chemotherapy 55: 35573563. 13. Croisier-Bertin D, Hayez D, Da Silva S, Labrousse D, Biek D, et al. In Vivo Efficacy of Ceftaroline Fosamil in a Methicillin-Resistant Pvl-Producing Staphylococcus Aureus Rabbit Pneumonia Model. Antimicrobial agents and chemotherapy. 14. Piroth L, Martin L, Coulon A, Lequeu C, Duong M, et al. Development of a new experimental 
model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin remedy by reproducing human pharmacokinetics. Antimicrobial agents and chemotherapy 43: 24842492. 15. Schroder AK, von der Ohe M, Kolling U, Altstaedt J, Uciechowski P, et al. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 Pluripotin receptor antagonist and chemokines, but fail to produce proinflammatory mediators. Immunology 119: 317327. 16. Malyak M, Smith MF Jr, Abel AA, Arend WP Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. Journal of clinical immunology 14: 2030. 17. Langereis JD, Oudijk EJ, Schweizer RC, Lammers JW, Koenderman L, et al. Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1beta synthesis by human neutrophi.Tine leukocidin and highly lethal necrotising pneumonia in young immunocompetent individuals. Lancet 359: 753759. three. Konig B, Koller M, Prevost G, Piemont Y, Alouf JE, et al. Activation of human effector cells by various bacterial toxins: generation of interleukin-8. Infection and immunity 62: 48314837. four. Perret M, Badiou C, Lina G, Burbaud S, Benito Y, et al. Cross-talk involving Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. Cellular microbiology 14: 10191036. five. Holzinger D, Gieldon L, Mysore V, Nippe N, Taxman DJ, et al. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. Journal of leukocyte biology 17460038 92: 10691081. 6. Williams MR, Azcutia V, Newton G, Alcaide P, Luscinskas FW Emerging mechanisms of neutrophil recruitment across endothelium. Trends in immunology 32: 461469. 7. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proceedings on the National Academy of Sciences from the United states of america of America 107: 55875592. eight. Dinarello CA, Simon A, van der Meer JW Treating inflammation by blocking interleukin-1 inside a broad spectrum of illnesses. Nature testimonials Drug discovery 11: 633652. 9. Giampietro C, Ridene M, Lequerre T, Costedoat Chalumeau N, Amoura Z, et al. Anakinra in adult-onset Still’s disease: long-term therapy in individuals resistant to standard therapy. Arthritis care & research 65: 822826. 10. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, et al. Is Panton-Valentine leukocidin the major virulence determinant in communityassociated methicillin-resistant Staphylococcus aureus disease The Journal of infectious ailments 194: 17611770. 11. Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, et al. The staphylococcal toxin panton-valentine leukocidin targets human c5a receptors. Cell host & microbe 13: 584594. 12. Croisier-Bertin D, Piroth 
L, Charles PE, Larribeau A, Biek D, et al. Ceftaroline versus ceftriaxone in a very penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing. Antimicrobial agents and chemotherapy 55: 35573563. 13. Croisier-Bertin D, Hayez D, Da Silva S, Labrousse D, Biek D, et al. In Vivo Efficacy of Ceftaroline Fosamil in a Methicillin-Resistant Pvl-Producing Staphylococcus Aureus Rabbit Pneumonia Model. Antimicrobial agents and chemotherapy. 14. Piroth L, Martin L, Coulon A, Lequeu C, Duong M, et al. Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin therapy by reproducing human pharmacokinetics. Antimicrobial agents and chemotherapy 43: 24842492. 15. Schroder AK, von der Ohe M, Kolling U, Altstaedt J, Uciechowski P, et al. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce proinflammatory mediators. Immunology 119: 317327. 16. Malyak M, Smith MF Jr, Abel AA, Arend WP Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. Journal of clinical immunology 14: 2030. 17. Langereis JD, Oudijk EJ, Schweizer RC, Lammers JW, Koenderman L, et al. Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1beta synthesis by human neutrophi.
